Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density

BackgroundIncreased mammographic density is one of the strongest independent risk factors for breast cancer. It is believed that one third of breast cancers are derived from breasts with more than 50% density. Mammographic density is affected by age, BMI, parity, and genetic predisposition. It is also greatly influenced by hormonal and growth factor changes in a woman's life cycle, spanning from puberty through adult to menopause. Genetic variations in genes coding for hormones and growth factors involved in development of the breast are therefore of great interest. The associations between genetic polymorphisms in genes from the IGF pathway on mammographic density and circulating levels of IGF1, its binding protein IGFBP3, and their ratio in postmenopausal women are reported here.MethodsSamples from 964 postmenopausal Norwegian women aged 55-71 years were collected as a part of the Tromsø Mammography and Breast Cancer Study. All samples were genotyped for 25 SNPs in IGF1, IGF2, IGF1R, IGF2R, IGFALS and IGFBP3 using Taqman (ABI). The main statistical analyses were conducted with the PROC HAPLOTYPE procedure within SAS/GENETICS™ (SAS 9.1.3).ResultsThe haplotype analysis revealed six haploblocks within the studied genes. Of those, four had significant associations with circulating levels of IGF1 or IGFBP3 and/or mammographic density. One haplotype variant in the IGF1 gene was found to be associated with mammographic density. Within the IGF2 gene one haplotype variant was associated with levels of both IGF1 and IGFBP3. Two haplotype variants in the IGF2R were associated with the level of IGF1. Both variants of the IGFBP3 haplotype were associated with the IGFBP3 level and indicate regulation in cis.ConclusionPolymorphisms within the IGF1 gene and related genes were associated with plasma levels of IGF1, IGFBP3 and mammographic density in this study of postmenopausal women.

[1]  D. Cox,et al.  An Analysis of Transformations , 1964 .

[2]  D. G. Hoel,et al.  ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer , 1983, Nature.

[3]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[4]  J. Kaprio,et al.  Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. , 1996, The Journal of clinical investigation.

[5]  C. Byrne,et al.  Studying mammographic density: implications for understanding breast cancer. , 1997, Journal of the National Cancer Institute.

[6]  C. Mantzoros,et al.  Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. , 1998, Epidemiology.

[7]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[8]  M A Astrahan,et al.  The detection of changes in mammographic densities. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  R. Shore,et al.  Serum insulin‐like growth factor‐I and breast cancer , 2000, International journal of cancer.

[10]  M. Pollak.  Insulin-like growth factor physiology and cancer risk. , 2000, European journal of cancer.

[11]  W. Willett,et al.  Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. , 2000, Cancer research.

[12]  G. Ooi,et al.  The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. , 2001, The Journal of endocrinology.

[13]  M. Stampfer,et al.  Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. , 2001, The Journal of clinical endocrinology and metabolism.

[14]  G. V. Ommen,et al.  Medical genomics , 2001, European Journal of Human Genetics.

[15]  M. Martin,et al.  Insulin-like growth factor-I and estrogen interactions in breast cancer. , 2002, The Journal of nutrition.

[16]  R. Krajcik,et al.  Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  David Tritchler,et al.  Heritability of mammographic density, a risk factor for breast cancer. , 2002, The New England journal of medicine.

[18]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[19]  F. Berrino,et al.  Fasting glucose is a risk factor for breast cancer: a prospective study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  N F Boyd,et al.  The association of breast mitogens with mammographic densities , 2002, British Journal of Cancer.

[21]  Zhihong Chen,et al.  Decreased expression of the mannose 6- phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells , 2002, BMC Cancer.

[22]  Beth A Reboussin,et al.  Postmenopausal hormone therapy and change in mammographic density. , 2003, Journal of the National Cancer Institute.

[23]  X. Shu,et al.  Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  Karla Kerlikowske,et al.  Mammographic breast density and family history of breast cancer. , 2003, Journal of the National Cancer Institute.

[25]  E. Riboli,et al.  Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden , 2002, Cancer Causes & Control.

[26]  B. Zee,et al.  Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable? , 2004, Breast Cancer Research and Treatment.

[27]  A. Tjønneland,et al.  Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[29]  X. Shu,et al.  Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  M. Ellis,et al.  Insulin-like growth factors in human breast cancer , 2004, Breast Cancer Research and Treatment.

[31]  Jennifer A Harvey,et al.  Quantitative assessment of mammographic breast density: relationship with breast cancer risk. , 2004, Radiology.

[32]  M. Yaffe,et al.  A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  Navin Parekh,et al.  Effects of mammographic density and benign breast disease on breast cancer risk (United States) , 2001, Cancer Causes & Control.

[34]  A. Saxton.  Genetic Analysis of Complex Traits Using SAS , 2004 .

[35]  D. Hunter,et al.  Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density , 2004, Breast Cancer Research and Treatment.

[36]  D. Trichopoulos,et al.  Leptin and insulin growth factor I in relation to breast cancer (Greece) , 2000, Cancer Causes & Control.

[37]  M. Pike,et al.  Greatly increased occurrence of breast cancers in areas of mammographically dense tissue , 2005, Breast Cancer Research.

[38]  I. Gram,et al.  Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer , 2005, Breast Cancer Research.

[39]  A. Roddam,et al.  A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk , 2005, British Journal of Cancer.

[40]  J. Bonneterre,et al.  Type 1 IGF receptor in human breast diseases , 2005, Breast Cancer Research and Treatment.

[41]  A. Paterson,et al.  Mammographic breast density as an intermediate phenotype for breast cancer. , 2005, The Lancet. Oncology.

[42]  J. Russo,et al.  Breast differentiation and its implication in cancer prevention. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  A. Ashworth,et al.  Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  M. Yaffe,et al.  Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density , 2005, Cancer Epidemiology Biomarkers & Prevention.

[45]  G. Colditz,et al.  Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study , 2007, Breast Cancer Research.

[46]  John L Hopper,et al.  The Heritability of Mammographically Dense and Nondense Breast Tissue , 2006, Cancer Epidemiology Biomarkers & Prevention.

[47]  A. Schally,et al.  Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study. , 2006, International journal of oncology.

[48]  I. Gram,et al.  Body mass index, waist circumference and waist–hip ratio and serum levels of IGF-I and IGFBP-3 in European women , 2006, International Journal of Obesity.

[49]  Nicholas J Wareham,et al.  IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. , 2006, Human molecular genetics.

[50]  X. Shu,et al.  Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study , 2007, Breast Cancer Research and Treatment.

[51]  M. Yaffe,et al.  Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. , 2006, Cancer research.

[52]  J. Peto,et al.  The Insulin-Like Growth Factor System and Mammographic Features in Premenopausal and Postmenopausal Women , 2006, Cancer Epidemiology Biomarkers & Prevention.

[53]  J. Chang-Claude,et al.  Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study , 2006, British Journal of Cancer.

[54]  Christopher A. Haiman,et al.  Haplotype-Based Association Studies of IGFBP1 and IGFBP3 with Prostate and Breast Cancer Risk: The Multiethnic Cohort , 2006, Cancer Epidemiology Biomarkers & Prevention.

[55]  I. Gram,et al.  Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women , 2007, International journal of cancer.

[56]  Laura Baglietto,et al.  Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women , 2008, Breast Cancer Research and Treatment.

[57]  I. Gram,et al.  Insulin-like Growth Factor and Mammographic Density in Postmenopausal Norwegian Women , 2007, Cancer Epidemiology Biomarkers & Prevention.

[58]  I. Gram,et al.  IGF‐I and mammographic density in four geographic locations: A pooled analysis , 2007, International journal of cancer.

[59]  I. Gram,et al.  Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study , 2007, Breast Cancer Research.

[60]  D. Grobbee,et al.  Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density , 2008, Breast Cancer Research and Treatment.

[61]  I. Gram,et al.  Different types of postmenopausal hormone therapy and mammographic density in Norwegian women , 2007, International journal of cancer.

[62]  Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density , 2008 .

[63]  M. Pike,et al.  IGF-1, IGFBP-1, and IGFBP-3 Polymorphisms Predict Circulating IGF Levels but Not Breast Cancer Risk: Findings from the Breast and Prostate Cancer Cohort Consortium (BPC3) , 2008, PloS one.

[64]  J. Brisson,et al.  Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels , 2008, Cancer Epidemiology Biomarkers & Prevention.

[65]  Breast cancer screening programme as setting for an adjunct research project: effect on programme attendance , 2008, Journal of medical screening.

[66]  N. Boyd,et al.  Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence , 2008, Breast Cancer Research.

[67]  T. Sellers,et al.  Can genes for mammographic density inform cancer aetiology? , 2008, Nature Reviews Cancer.